Xiamen Jiarong Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Industrial Manufacturing
  • ISIN: CNE100005CB8
CNY
58.56
-2.51 (-4.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore

Dashboard

1

The company is Net-Debt Free

  • Poor long term growth as Net Sales has grown by an annual rate of -8.63% and Operating profit at -43.19% over the last 5 years
  • The company is Net-Debt Free
  • The company has been able to generate a Return on Equity (avg) of 7.27% signifying low profitability per unit of shareholders funds
2

Poor long term growth as Net Sales has grown by an annual rate of -8.63% and Operating profit at -43.19% over the last 5 years

 
3

With a fall in Net Sales of -3.76%, the company declared Very Negative results in Mar 26

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Industrial Manufacturing

stock-summary
Market cap

CNY 3,106 Million (Small Cap)

stock-summary
P/E

180.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.41

stock-summary
Return on Equity

1.63%

stock-summary
Price to Book

1.76

Revenue and Profits:
Net Sales:
141 Million
(Quarterly Results - Jun 2026)
Net Profit:
13 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.69%
0%
-5.69%
6 Months
18.3%
0%
18.3%
1 Year
94.81%
0%
94.81%
2 Years
274.42%
0%
274.42%
3 Years
132.29%
0%
132.29%
4 Years
161.55%
0%
161.55%
5 Years
0%
0%
0.0%

Xiamen Jiarong Technology Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-8.63%
EBIT Growth (5y)
-43.19%
EBIT to Interest (avg)
27.20
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
0.28
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
88.66%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.00%
ROE (avg)
7.27%

Valuation key factors

Factor
Value
P/E Ratio
180
Industry P/E
Price to Book Value
2.94
EV to EBIT
290.67
EV to EBITDA
93.76
EV to Capital Employed
4.30
EV to Sales
8.84
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.48%
ROE (Latest)
1.63%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is 23.64% vs -19.52% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -6.47% vs 15.83% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "141.20",
          "val2": "114.20",
          "chgp": "23.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "14.50",
          "val2": "16.70",
          "chgp": "-13.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.80",
          "val2": "3.40",
          "chgp": "11.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.00",
          "val2": "13.90",
          "chgp": "-6.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "23.30%",
          "val2": "51.80%",
          "chgp": "-2.85%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -8.59% vs 0.31% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 9.00% vs -17.16% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "506.70",
          "val2": "554.30",
          "chgp": "-8.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "73.10",
          "val2": "81.10",
          "chgp": "-9.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "1.80",
          "chgp": "5.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.50",
          "val2": "14.50",
          "chgp": "-48.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "52.10",
          "val2": "47.80",
          "chgp": "9.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "59.40%",
          "val2": "42.10%",
          "chgp": "1.73%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'26 - YoYstock-summary

Jun'26
Jun'25
Change(%)
Net Sales
141.20
114.20
23.64%
Operating Profit (PBDIT) excl Other Income
14.50
16.70
-13.17%
Interest
0.30
0.30
Exceptional Items
3.80
3.40
11.76%
Consolidate Net Profit
13.00
13.90
-6.47%
Operating Profit Margin (Excl OI)
23.30%
51.80%
-2.85%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2026 is 23.64% vs -19.52% in Jun 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2026 is -6.47% vs 15.83% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
506.70
554.30
-8.59%
Operating Profit (PBDIT) excl Other Income
73.10
81.10
-9.86%
Interest
1.90
1.80
5.56%
Exceptional Items
7.50
14.50
-48.28%
Consolidate Net Profit
52.10
47.80
9.00%
Operating Profit Margin (Excl OI)
59.40%
42.10%
1.73%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is -8.59% vs 0.31% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 9.00% vs -17.16% in Dec 2024

stock-summaryCompany CV
About Xiamen Jiarong Technology Co., Ltd. stock-summary
stock-summary
Xiamen Jiarong Technology Co., Ltd.
Industrial Manufacturing
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Footer loading
Share Price | Xiamen Jiarong Technology Co., Ltd. Stock Analysis & Recommendation